Giuseppe Claudio Viscomi,Ferdinando Mannello,Cristiana Bruno
申请号：
US13642510
公开号：
US20130045946A1
申请日:
2011.04.20
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention describes sulodexide or at least one of its components for use in the reduction of circulating matrix metalloproteinase (MMPs), in particular MMP-9. Sulodexide and its composition are useful for the treatment of pathologies wherein the MMPs are involved, such as cardiovascular disease, cardiovascular disease caused by diabetes, varicose veins, chronic venous insufficiency (CVI), gastrointestinal ulcers, pulmonary disease, and neoplastic pathologies.
